Jialiang Medical Joins Brain-Computer Interface Technology Innovation and Industry Service Alliance, Advances Toward IPO
GenLight
Innovative Medical Device Solution Provider
On September 28, the theme was"Intelligent Innovation, Brain-Linked Future"TheConference on Brain-Computer Interface Innovative Technologies Empowering Industrial ApplicationsThe event was held in Qixia District, Nanjing City. Li Zhongjun, Vice Governor of Jiangsu Province; Jiang Min, Vice Mayor of Nanjing City; Sun Haidong, Secretary of the Qixia District Party Committee, Secretary of the Nanjing Economic and Technological Development Zone Party Working Committee, and Secretary of the Xianlin University Town Party Working Committee, along with other provincial, municipal, and district leaders, joined representatives from Jiangsu Provincial People's Hospital, several universities, medical institutions, and enterprises to collectively witness the simultaneous launch of the Jiangsu Brain-Computer Interface Research Institute, the Brain-Computer Interface Technology Innovation and Industry Service Alliance, and the Brain-Computer Interface Special Committee of the Jiangsu Intelligent Medical Engineering Society.
Strong Alliance to Promote Industrial Integration and Innovation
The "Brain-Computer Interface Technology Innovation and Industry Service Alliance" is chaired by Professor Zheng Hairong, an academician of the Chinese Academy of Sciences and Vice President of Nanjing University. It brings together resources and strengths from enterprises, universities, research institutions, and clinical hospitals to jointly promote the deep integration and development of brain-computer interface technology in fields such as medical rehabilitation, human-computer interaction, and intelligent equipment.
Genlight Neurotech Invited to BecomeMember Unit of the Brain-Computer Interface Technology Innovation and Industry Service AllianceThis marks that Genlight Neurotech's research and development capabilities and industrial potential in the field of brain science and neurotechnology have gained high recognition from the industry. It also indicates that the company will, on a broader platform, collaborate with industry chain partners to jointly promote the clinical transformation and industrialization process of brain-computer interface technology.
Focus on Clinical Practice, Accelerate Technology Implementation and Application
Brain-computer interface technology is hailed as the next generation of revolutionary medical treatments, showing great potential in treating epilepsy, Parkinson's disease, depression, spinal cord injuries, and other fields. However, the ultimate success of the technology depends on its reliability, safety, and ease of use in clinical applications.
Dr. Peng Cao, General Manager of Genlight Neurotech, stated: "We are highly honored to join the alliance. Brain-computer interface represents not only the pinnacle of technology but also a beacon of hope for life. The core mission of Genlight Neurotech is to transform cutting-edge technology into clinical solutions that can effectively alleviate patients' suffering. Through close collaboration with top research teams and clinical experts within the alliance, we will be able to better understand clinical needs, optimize product design, and accelerate the development of our brain-computer interface-related products."
Looking Ahead, Building a New Industrial Ecosystem
This conference brought together many experts, scholars, and enterprise representatives in the field of brain-computer interface to jointly explore the application prospects of this innovative technology in medical treatment, rehabilitation, and other fields, providing an important communication platform for promoting the industrial development of brain-computer interface technology.
As a member unit of the alliance, Genlight Neurotech will continue to focus on the development of brain-computer interface technology neuromodulation devices, build platform technologies, expand multiple indication products, and bring hope to more patients in the future.
